PET imaging of new target CDK19 in prostate cancer.

Purpose: Prostate-specific membrane antigen (PSMA)-positron emission tomography (PET) is a superior method to predict patients' risk of cancer progression and response to specific therapies. However, its performance is limited for neuroendocrine prostate cancer (NEPC) and PSMA-low prostate cancer ce...

Descripción completa

Detalles Bibliográficos

Publicado en:	European Journal of Nuclear Medicine & Molecular Imaging Vol. 50; no. 11; pp. 3452 - 3465
Autores principales:	Dai, Dong, Yu, Jiang, Huang, Ting, Li, Yansheng, Wang, Ziyang, Yang, Shuangmeng, Li, Shuai, Li, Yanli, Gou, Wenfeng, Li, Deguan, Hou, Wenbin, Fan, Saijun, Li, Yiliang, Zhao, Yu
Formato:	Journal Article
Publicado:	Springer Nature Sep2023
Acceso en línea:	Ver este registro en EBSCOhost